DE69104314T2 - Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen. - Google Patents
Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.Info
- Publication number
- DE69104314T2 DE69104314T2 DE69104314T DE69104314T DE69104314T2 DE 69104314 T2 DE69104314 T2 DE 69104314T2 DE 69104314 T DE69104314 T DE 69104314T DE 69104314 T DE69104314 T DE 69104314T DE 69104314 T2 DE69104314 T2 DE 69104314T2
- Authority
- DE
- Germany
- Prior art keywords
- dimethylamino
- propyl
- treatment
- cerebrovascular disorders
- phenylphthalenes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK213290A DK213290D0 (da) | 1990-09-06 | 1990-09-06 | Treatment of cerebrovascular disorders |
SG165594A SG165594G (en) | 1990-09-06 | 1994-11-16 | 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69104314D1 DE69104314D1 (de) | 1994-11-03 |
DE69104314T2 true DE69104314T2 (de) | 1995-02-16 |
Family
ID=26066379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69104314T Expired - Lifetime DE69104314T2 (de) | 1990-09-06 | 1991-08-16 | Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0474580B1 (de) |
JP (1) | JPH085787B2 (de) |
KR (1) | KR970002246B1 (de) |
AT (1) | ATE112166T1 (de) |
AU (1) | AU644204B2 (de) |
CA (1) | CA2049368C (de) |
DE (1) | DE69104314T2 (de) |
DK (2) | DK213290D0 (de) |
HK (1) | HK21595A (de) |
IE (1) | IE72160B1 (de) |
IL (1) | IL98968A (de) |
NZ (1) | NZ239437A (de) |
SG (1) | SG165594G (de) |
ZA (1) | ZA916187B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3526581B2 (ja) * | 1997-07-08 | 2004-05-17 | ハー・ルンドベック・アクティーゼルスカブ | シタロプラムの製造方法 |
JP4674339B2 (ja) * | 1998-08-07 | 2011-04-20 | 三菱化学株式会社 | 脳損傷の予防・治療剤 |
WO2000023431A1 (en) * | 1998-10-20 | 2000-04-27 | H. Lundbeck A/S | Method for the preparation of citalopram |
CZ300408B6 (cs) | 1998-12-23 | 2009-05-13 | H. Lundbeck A/S | Zpusob výroby 5-kyanoftalidu |
PL198024B1 (pl) | 1999-04-14 | 2008-05-30 | Lundbeck & Co As H | Sposób wytwarzania citalopramu, związki pośrednie i ich zastosowanie do wytwarzania citalopramu |
ITMI991581A1 (it) * | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
GB2357762B (en) | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
BG64901B1 (bg) * | 2000-05-29 | 2006-08-31 | H. Lundbeck A/S | Метод за получаване на циталопрам |
CA2354880C (en) * | 2000-08-18 | 2003-06-03 | H. Lundbeck A/S | Method for the preparation of citalopram |
KR100439329B1 (ko) * | 2000-12-22 | 2004-07-07 | 하. 룬트벡 아크티에 셀스카브 | 순수한 시탈로프람의 제조방법 |
BG65515B1 (bg) * | 2002-07-26 | 2008-10-31 | H. Lundbeck A/S | Метод за получаване на 5-цианофталид |
EP2343073A3 (de) | 2003-12-11 | 2011-10-12 | Sepracor Inc. | Kombination eines Beruhigungsmittels und eines Neurotransmittermodulators und Verfahren zur Verbesserung der Schlafqualität und Behandlung von Depressionen |
TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
EP2008653A1 (de) * | 2007-06-28 | 2008-12-31 | Charité-Universitätsmedizin Berlin | Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten |
DE102007051090A1 (de) | 2007-06-28 | 2009-01-08 | Charité - Universitätsmedizin Berlin | SSRI zur Behandlung neuronaler Krankheiten |
CN104005415B (zh) * | 2014-02-18 | 2015-12-02 | 中铁十六局集团北京轨道交通工程建设有限公司 | 微风化花岗岩中地下连续墙的高效成槽施工方法 |
CN106871753B (zh) * | 2017-01-04 | 2018-10-16 | 中铁隧道集团有限公司 | 一种用于提高水平岩层隧道成型的装药方法 |
-
1990
- 1990-09-06 DK DK213290A patent/DK213290D0/da not_active Application Discontinuation
-
1991
- 1991-07-25 IL IL9896891A patent/IL98968A/en not_active IP Right Cessation
- 1991-07-30 IE IE268291A patent/IE72160B1/en not_active IP Right Cessation
- 1991-08-06 ZA ZA916187A patent/ZA916187B/xx unknown
- 1991-08-16 EP EP91610063A patent/EP0474580B1/de not_active Expired - Lifetime
- 1991-08-16 DE DE69104314T patent/DE69104314T2/de not_active Expired - Lifetime
- 1991-08-16 CA CA002049368A patent/CA2049368C/en not_active Expired - Lifetime
- 1991-08-16 AT AT91610063T patent/ATE112166T1/de not_active IP Right Cessation
- 1991-08-16 DK DK91610063.9T patent/DK0474580T3/da active
- 1991-08-16 NZ NZ239437A patent/NZ239437A/en not_active IP Right Cessation
- 1991-08-19 KR KR1019910014255A patent/KR970002246B1/ko not_active IP Right Cessation
- 1991-08-20 AU AU82594/91A patent/AU644204B2/en not_active Ceased
- 1991-09-04 JP JP3224192A patent/JPH085787B2/ja not_active Expired - Fee Related
-
1994
- 1994-11-16 SG SG165594A patent/SG165594G/en unknown
-
1995
- 1995-02-16 HK HK21595A patent/HK21595A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA916187B (en) | 1992-04-29 |
EP0474580A3 (en) | 1992-06-03 |
DK213290D0 (da) | 1990-09-06 |
IE912682A1 (en) | 1992-03-11 |
SG165594G (en) | 1995-05-12 |
KR920005983A (ko) | 1992-04-27 |
IE72160B1 (en) | 1997-03-26 |
JPH085787B2 (ja) | 1996-01-24 |
EP0474580B1 (de) | 1994-09-28 |
DK0474580T3 (da) | 1995-04-03 |
JPH04244024A (ja) | 1992-09-01 |
CA2049368C (en) | 2001-10-23 |
IL98968A (en) | 1996-06-18 |
AU8259491A (en) | 1992-03-12 |
IL98968A0 (en) | 1992-07-15 |
KR970002246B1 (ko) | 1997-02-26 |
HK21595A (en) | 1995-02-24 |
NZ239437A (en) | 1997-02-24 |
AU644204B2 (en) | 1993-12-02 |
CA2049368A1 (en) | 1992-03-07 |
EP0474580A2 (de) | 1992-03-11 |
DE69104314D1 (de) | 1994-11-03 |
ATE112166T1 (de) | 1994-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69104314T2 (de) | Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen. | |
NO922147L (no) | Heterocykliske derivater | |
DK0530505T3 (da) | Hydantoinderivater | |
FI941378A0 (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
FI913478A0 (fi) | Diazinderivat. | |
DE69200160T2 (de) | Angiotensin-II-Antagonisten. | |
ATE245418T1 (de) | Verwendung von thiazolidindionen zur behandlung von atherosklerose und essstörungen | |
DE3888340T2 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
DE69018726D1 (de) | Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen. | |
ATE85334T1 (de) | Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung. | |
ES8602723A1 (es) | Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas. | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
DE3650311D1 (de) | Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie. | |
ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
ATE53205T1 (de) | Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung. | |
DE69327077T2 (de) | Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen | |
RO95572A2 (ro) | Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona | |
ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
DE68906028T2 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |